Literature DB >> 17269667

Nanoparticle-mediated drug delivery and gene therapy.

Sha Jin1, Kaiming Ye.   

Abstract

Biomedical application of nanotechnology is a rapidly developing area that raises new prospect in the improvement of diagnosis and treatment of human diseases. The ability to incorporate drugs or genes into a functionalized nanoparticle demonstrates a new era in pharmacotherapy for delivering drugs or genes selectively to tissues or cells. It is envisioned that the transfer of nanoengineering capability into disease therapy will provide constant and concentrated drug delivery to targeted tissues, minimizing systemic side effects and toxicity. We have in this article highlighted the recent state of the art in nanomedicine, focusing particularly on the achievement of nanotechnology in nanoscale drug and gene delivery in vitro and in vivo. In addition, a specific emphasis has been placed on the use of nanotechnology to improve controlled drug release and sustainable drug delivery in solid tumors and on new drug therapies for age-related neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17269667     DOI: 10.1021/bp060348j

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  46 in total

Review 1.  Biocompatible quantum dots for biological applications.

Authors:  Sandra J Rosenthal; Jerry C Chang; Oleg Kovtun; James R McBride; Ian D Tomlinson
Journal:  Chem Biol       Date:  2011-01-28

2.  Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.

Authors:  Christopher M Hine; Andrei Seluanov; Vera Gorbunova
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

Review 3.  Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules.

Authors:  Shyam Sundar; Vijay Kumar Prajapati
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Reversible pH lability of cross-linked vault nanocapsules.

Authors:  Marcella Yu; Benny C Ng; Leonard H Rome; Sarah H Tolbert; Harold G Monbouquette
Journal:  Nano Lett       Date:  2008-09-20       Impact factor: 11.189

5.  Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.

Authors:  Hongzhi Xie; Jing Yang; Yechen Han; Xueqing Zhu; Quan Fang
Journal:  Exp Ther Med       Date:  2015-04-21       Impact factor: 2.447

Review 6.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

7.  Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release.

Authors:  Seong Deok Kong; Marta Sartor; Che-Ming Jack Hu; Weizhou Zhang; Liangfang Zhang; Sungho Jin
Journal:  Acta Biomater       Date:  2012-11-10       Impact factor: 8.947

8.  Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus.

Authors:  Amit A Vernekar; Gilles Berger; Anna E Czapar; Frank A Veliz; David I Wang; Nicole F Steinmetz; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2018-03-19       Impact factor: 15.419

9.  Self-assembled particles of N-phthaloylchitosan-g-polycaprolactone molecular bottle brushes as carriers for controlled release of indometacin.

Authors:  Youju Huang; Liangbin Li; Yue'e Fang
Journal:  J Mater Sci Mater Med       Date:  2009-09-26       Impact factor: 3.896

10.  Enhancement of microbial hydroxylation of 13-ethyl-gon-4-ene-3,17-dione by Metarhizium anisopliae using nano-liposome technique.

Authors:  Meiqing Feng; Ziwei Liao; Lei Han; Jiyang Li; Li Ye
Journal:  J Ind Microbiol Biotechnol       Date:  2014-02-19       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.